Patrick Loofbourrow


I enjoy helping emerging companies bring new and innovative products to the market.

Patrick is a co-founder of Cooley’s Shanghai and Singapore offices and splits his time across Cooley’s Asia and California offices. Patrick's practice focuses on the representation of high-growth emerging technology and life sciences companies as well as venture capital and other firms that invest in those companies across Asia and the US. Concentrating on corporate and securities law, he has counseled company clients and investors in a wide variety of projects, including company formations, spin-offs, private and public financings, initial public offerings, mergers and acquisitions, joint venture and other strategic transactions, employee equity incentives, corporate governance matters and SEC reporting and compliance. Patrick counsels companies in a variety of industries, including fintech, ecommerce, edtech, software, digital health, biotechnology, healthcare and medical devices.

Download full bio 


  • Carousell Group Reaches Unicorn Status With $100 Million Investment 

  • Japan’s Paidy Agrees to Sell to PayPal for $2.7 Billion 

  • Cytek Biosciences – $200 Million IPO 

  • Ambrx Biopharma – $126 Million IPO 

  • Meesho’s Valuation Reaches $2.1 Billion With Latest Funding Round 

  • View all


  • University of San Diego School of Law
    JD, summa cum laude, Order of the Coif, 1999

  • Stanford University
    AB, Anthropology, International Relations

Admissions & Credentials



  • American Bar Association

  • San Diego County Bar Association